BSEAGM/EGM4d ago · 3 Aug 2026, 03:55 pm
Notice of the 41st Annual General Meeting of the Company Schedule to be held on Friday, 04th September, 2026, through VC/OAVM.
Jenburkt Pharmaceuticals Ltd · 524731
✦ AI SummaryResults
Jenburkt Pharmaceuticals Ltd has announced the notice of its 41st Annual General Meeting (AGM) to be held on September 4, 2026, through video conferencing. The meeting will consider various resolutions, including the adoption of audited financial statements, dividend declaration, and reappointment of the Whole Time Director and CFO.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Jenburkt Pharmaceuticals Ltd - 524731 - Notice Of The 41St Annual General Meeting Of The Company Schedule To Be Held On Friday, 04Th September, 2026 Through VC/OAVM.